We present here a new method for non-radioactive labeling of substance P (SP) to demonstrate the distribution of its binding sites in histological sections. The peptide was labeled at the primary amino group with a 1.4-nm gold partide. In Wastern blots of membrane fractions of rat spinal cord, specific binding occutred at 38 and 58 KD. This binding was competitively suppressed by adding the native peptide. In addition, the SPgold conjugate was able to displace the comsponding usI-labeled peptide from binding proteins. In histological sections, binding sites could be shown in various parts of rat brain and spinal cord. The distribution patterns were comparable to those found in studies Using autoradiographic methods. Adding the native peptide or a neurokinin 1 receptor agonist markedly reduced labeling of the tissue, whereas only a slight reduction was obtained after adding neurokinin A. Therefore, SP could be spetifically labeled with a 1.4-nm gold particle to demonstrate its binding sites. This new method combines the advantages of reaptor-ligand 6 i t y binding with a non-radioactive detpion system. It can be used for labeling peptides in general and therefore o&rs an altematiw or addition to other methods used in studv of the distribution of membrane receptors. (J Hisrochem Cytochem 43:821-827, 1995) 
Introduction
Peptide binding sites can be visualized by the use of radioactively labeled ligands followed by autoradiography or by the use of peptides conjugated with biotin orfluorochromes (e.g., Bowden et al.. 1994; Anton et al., 1991) . Working with radioactively labeled ligands is well suited for mapping of proteins with high binding activity for peptides, but it requires radiochemical facilities and working with radioactively labeled ligands has the disadvantage of commonly requiring exposure times of up to several weeks.
With the development of molecular biology it became possible to produce specific antibodies against peptide receptors. However, their production is very laborious and time-consuming. Therefore, only a small number of antisera are available thus far. The aim of the present study was to circumvent these disadvantages and to combine the advantages of a receptor-ligand affinity-labeling system with a non-radioactive detection system by using peptide-gold conjugates.
Recently, a gold labeling reagent consisting of a single organic reactive sulfo-N-hydroxy succinimide functionally incorporated into a ligand on the surface of a 1.4-nm gold particle (NHS Nanogold) has become available. This compound has a specific reactivity towards primary amines and can be covalently linked to any protein or peptide bearing an accessible primary amino group. Successful labeling of proteins such as antibodies or subunits of ATPase with 1.4-nm gold particles (monomaleimido-Nanogold) has already been obtained (Hainfeld and Furuya, 1992; Wilkens and Capaldi, 1992) . This gold compound, however, binds to free sulfhydryl groups of the proteins.
In the present study we examined whether this new gold compound can be used to label substance P (SP) and to demonstrate its binding sites in histological sections of the rat brain and spinal cord. Because many autoradiographic studies have already shown the distribution of SP binding sites in rat central nervous system (e.g., Saffroy et al., 19%; Yashpal et al., 1990; Mantyh et al., 1989) , it was possible to compare our results with previous data. Some aspects of this work have already been communicated briefly (Segond von Banchet and Heppelmann, 1994a,b) .
Materials and Methods
Preparation of the Peptide-Gold Conjugate. One pmol SP was dissolved in 500 p1 HEPES (20 mmol, pH 7.4). added to 500 p1 of 30 nmol Nanogold reagent (NHS Nanogold; Nanoprobes, Stony Brook, NY or Bi-kDa -5 8 , :
38,
India-ink '251-SP '251-SP 1251-SP SP-gold SP-gold gold + + SP SP-gold oTrcnd. Koln, Germany) dissolved in ddH20, and incubated for 1 hr at room temperature (RT) by rotating the micro test rubes (50 rpm). The Nanogold reagent was added to an cxccss of the peptide. as labeled and unlabeled peptides can easily be separated according to marked differences in their molecular weights (SP 1.517 K& NHS Nanogold "J15 KD).
To separate peptide-gold conjugates from the unbound peptides we used membrane centrifugation (Amicon Centricon-IO system) with a membrane molecular weight cut-off of 10 KD. The solution containing peptide-gold conjugate and unbound peptide was pipetted into the sample reservoir and spun at 14.000 x g for 65 min at 4'C. The filter carrying the labeled peptides was placed upside down into a new vial and spun again for 3 min at 1000 x g and 4'C to transfer the peptide-gold conjugate to the vial. This separation was repeated twice to remove all unbound pcptides. Finally, the peptide-gold conjugates were diluted in 10 mmol sodium phosphate-buffered saline (PBS; 150 mmol NaCI, pH 7.4) containing 10 mmol sodium azide, 1% bovine serum albumin BSA; w/v). leupeptin (4 pglml), and 2 mol sucrose. aliquottcd into 100 pI probes, and stored at -20°C.
Binding Experiments on Wmcrn blots. Lumbar spinal cord segments were taken from male Wistar rats (3-6 months old) which had been killed by an overdose of thiopental-Na (Byk Gulder; Konstanz, Germany). They were stored at -70'C in a modified Krebs-Henseleit-Ringer solution (KHR-S) containing 5.53 mmol CaC12, 4.74 mmol KCI, 1.19 mmol KH2P04, 1.19 mmol MgSO4, 118.54 mmol NaCI. 25 mmol NaHCO3. 50 mmol HEPES, 5 mmol phenylmethylsulfonyl fluoride. and 10 mmol sodium azide. pH 7.5.
When thawed. the tissue samples were homogenized in ice-cold KHR-S (1000 rpm). The homogenatcs were Centrifuged at 21,000 x g for 60 min at 4'C. The pellets were re-suspended with 500 wl KHR-S plus 5 mmol ethylenediaminctetracetic acid (EDTA). 1 mmol dithiothrcitol (DTT), and 1% 3-[(3-cholamidopropyI)-dimcthylammonio]-~-propanesulfonate (CHAPS) (wlv) and incubated for 1 hr on ice. The samples were centrifuged (21,000 x g, 60 min), the collected supernatants were sonicated, washed twice with KHR-S, re-suspended and centrifuged again at 21,000 x g for sodium dodecylsulfatc (SDS). 10% glycerol. 5% 2-mercaptocthano1, 3%
Bromphenol Blue) and incubated for 30 min at RT. After that, protein samples were separated by the SDS-PAGE method (T = 7.5% or 10%). originally described by Laemmli (1970) . in a vertical electrophoresis (Biometra; Giittingen, Germany) and transferred to a nitrocellulose membrane (Schleicher & Schiill; Dassel. Germany) by a transblot apparatus (Biometra) at 5 mA/cm2 gel for 20 min and the buffer system originally described by Tawbin et al. (1979) . Unoccupied sites on the nitrocellulose membranes were blocked by incubation with 5 % gelatin (v/v, from coldwater fish skin) in PBS for 30 min at 37%. Nitrocellulose membraneswere then incubated for 2 hr at RT with the peptide-gold conjugates (3 nmol final concentration) diluted in PBS containing 0.1% gelatin (v/v), bacitracin (40 wglml), leupeptin (4 pglml), and chymostatin (2 pg/ml). After washing with 0.1% gelatin (vlv) in PBS, nitrocellulose membranes were incubated with 1% glutaraldehyde (vlv) in PBS plus 0.1% gelatin for 30 min. After two further washing steps, first in PBS and then in ddH20. the blots were dmloped by incubation with a conventional silver enhancement solution (pH 5.5: e.g., R-Gent. BioTrend) for 15-20 min at RT. The reaction was stopped by washing in ddHzO.
For control of the binding specificity. nitrocellulose membranes were incubated with gold-labeled peptides plus 1 ~o l of the native peptide. To acclude unspecific binding ofthe Nanogold panicla. nitrocellulose membranes were incubated with 3 nmol NHS Nanogold.
To control the quality of the blotting, gels were silver stained according to Heukeshmn and Dcrnick (1985) and sheets of nitrocellulose membrane were stained with India ink (Pelikan) diluted 1:500 in PBS containing 0.3% Tween 20 (v/v).
Autoradiography. After three washings with PBS for 5 min each, nitrocellulose membrane strips were incubated mrnight in the same buffer con- Binding sites were visualized with silver enhancement. Intense binding was seen in the outer layers of the cortex (C). the amygdaloid nuclei (AN), the hippocampus (HI), and the hypothalamus (HY). whereas weak or no binding occurred in most parts of the thalamus (TH) and in the lateral habenular nuclei (LH). Bar = 1 mm. Cilmmol, Code IM 157, from Amersham) and 0.1% gelatin (v/v). bacitracin (40 pglml). leupeptin (4 pglml). and chymostatin (2 pglml) at 4'C. As a control, 1 w o l of native SP was added to the incubation solution.
To estimate the binding specificity of SP-gold conjugates. membrane strips were incubated with ['"I]-SP with the addition of 30 nmol SP-gold conjugate.
After the incubation with the radioligand. membrane smpswere washed twice in PBS (5 min each) and four times in ddHlO (10 sec each). Thereafter, they were dried and placed in contact with MRB film (Cea. Sweden). for 1 week. Films were developed with G153 (AGFA).
Binding Experiments on Tissue Sections. Cryostat sections (30 km) of unfucd brains and lumbar spinal cords wcm thaw-mounted onto Vmbondcoated slides (Vector Laboratories; Peterborough. UK) and stored at -70%.
Before the binding experiments, sections were fucd with 0.5% glutaraldehyde in PBS for 30 min. After a 5-min washing with PBS they were incubated with 50 nmol glycine in PBS for 30 min and thereafter with 5% BSA and 0.1% gelatin in PBS for 30 min to block free aldehyde groups and unspecific binding sites within the tissue. The slides were then covered with 3 nmol SP-Nanogold in PBS plus 0.1% acetylated and linearized bovine serum albumin (BSA-C). bacitracin (40 pglml). leupeptin (4 pglml), and chymostatin (2 pglml). After an overnight incubation at 4'C in a moist 1 4 chamber. sections were cxtensiwly rinxd in PBS plus 0.1% BSA-C and thereafter in PBS. The sections were post-fixed with 2% glutaraldehyde in PBS for 2 min. After extensive washing with PBS and ddH20, the gold was intensified with silver enhancer (R-Gent. pH 5.5) for 30-50 min. The rcaction was stopped by washing in ddH20.
Control Incubations. To test for specificity of the SP-gold binding in the tissue, sections were incubated with 3 nmol SFLgold together with 1 pmol native SP. with 1 mol of the specific neurokinin 1 (NK1) receptor agonist [Sar9. Met(O2)"J-SP. or with 1 w o l neurokinin A. a neuropeptide that predominantly binds at the NK2-receptor (Mussap et al.. 1993) . In addition, some slides were incubated with 3 nmol NHS Nanogold to control against unspecific binding of the Nanogold particles.
Results

Biochemical Demonstration of Substance P Binding
Sites in Tissue Homogenates
To determine the binding specificity of the SP-gold conjugates, we performed ligand binding assays on nitrocellulose membranes. Solubilized proteins of the spinal cord membrane fraction were separated by gel electrophoresis, transferred onto nitrocellulose membranes, and stained with India ink dye (first strip in Figure 1 ).
When the nitrocellulose strips were incubated with [ 1251]-SP, specific binding resulted at proteins with molecular masses of about 38 and 58 KD shown by autoradiography (Figure 1 ). Binding of [lz'I]-SP was completely inhibited by addition of native SP or SP-gold (Figure 1 ).
Incubation with SP-gold produced binding to proteins with the same molecular masses of about 38 and 58 KD visualized by silver enhancement (Figure 1) . This binding was abolished by adding an excess of native SP (Figure 1) . To exclude unspecifc binding to membrane proteins by the gold particles, nitrocellulose membranes with the separated membrane proteins were incubated with the NHS Nanogold solution (Figure 1) . In no case did any specific binding occur, indicating the ability of peptide-gold conjugates to recognize peptide binding proteins in a very specific way. 
Distribution of Substance P Binding Sites in Histological Sections
To examine whether gold-labeled peptides can be used to demonstrate their binding sites in histological sections, cryostat sections of rat central nervous system were incubated with SP-gold. After silver enhancement, clearly visible binding could be seen in various parts of the brain and the spinal cord.
Some examples of the SP-gold binding are shown in Figures  2-7 . Intense binding occurred in the outer layers of the cortex, the amygdaloid nuclei, the hippocampus, and the hypothalamus (Figure 2 ). In the same section, weak or no binding was found in most parts of the thalamus and in the lateral habenular nuclei ( Figure  2 ). In the mesencephalon, SP-gold predominantly bound to the superficial layers of the superior colliculi and to the periaqueductal gray (Figure 4) . Other examples of intense binding were found in the inferior olive and the lateral reticular nucleus ( Figure 5 ). SP-gold also bound to the cerebral arteries, where intense binding to the endothelial cells occurred ( Figure 6 ).
In the spinal cord, binding occurred throughout the gray matter. The highest densities were found in the superficial dorsal horn (Laminae I and 11) and in Lamina X, as well as along the ventromedial border of the dorsal horn ( Figure 3) . Especially in the ventral horn, SP-gold bound on many perikarya of different sizes (Figure 7) . No binding was obtained in the white matter.
Control Incubations
To test the specificity of SP-gold binding to neural tissue, several control incubations were performed (Figure 8 ). Almost no binding was obtained after incubation with SP-gold in the presence of native SP or a specific NK1-receptor agonist (Sar9, [Met ( 0 2 ) " ] -SP). In contrast, addition of neurokinin A to the SP-gold incubation resulted only in a slight reduction in the intensity of the binding. Incubation with the NHS Nanogold solution led to no specific binding within the sections.
Discussion
The present study shows that SP labeled with NHS Nanogold can be used to demonstrate its binding sites in neural tissue. In Western blots of tissue homogenates of the rat spinal cord, Nanogoldlabeled SP specifically bound at proteins with molecular masses of 38 and 58 KD. This was identical to the results obtained after incubation with radioactively labeled SP. These molecular masses of the binding proteins are comparable to data obtained with antibodies against the NK1 receptor (Shigemoto et al., 1992; Gilbert et al., 1992) . Positive immunoreactions have been obtained with proteins of molecular masses of about 46 KD (Gilbert et al., 1992) or between 45 and 80 KD (Shigemoto et al., 1993) . After characterization of a functional cDNA clone, the molecular mass of the rat SP receptor has been calculated at about 46 KD (Yokota et al., 1989) . The diversity of the molecular masses found by these groups and by us may be due to a variety of carbohydrates linked to N-glycosylation sites of the receptor, degraded products of proteins generated during membrane preparation, or the existence of different SP binding proteins.
Labeling the peptide at the N-terminus with a 1.4-nm gold par-ticle did not appear to influence the binding at the receptor. Binding experiments suggested that tachykinin peptides bind by the C-terminus that penetrates into a ligand binding pocket of the receptor (Huang et al., 1994; Gether et al., 1993) . Although SP and the gold label markedly differ in size, this did not influence the binding of the labeled SP. However, it remains to be shown whether binding of peptides with a lesser number of amino acids may be hindered stereologically by the size of the gold label. In addition, receptors of other peptides may be rendered nonfunctional after frozen section processing and fixation in 0.5% glutaraldehyde.
In histological sections of the rat central nervous system, Nanogold-labeled SP bound at different parts of the brain and spinal cord. The distribution patterns were comparable to those obtained after incubation with radioactively labeled SP (e.g., Saffroy et al., 1994; Yashpal et al., 1990; Mantyh et al., 1989) or with antibodies against the SP receptor (Nakaya et al., 1994) . SELgold bin@ could be seen at single perikarya, demonstrating the high spatial resolution of this method.
Autoradiographic methods to demonstrate the distribution of binding sites ("membrane receptors") in histological sections have the advantage that almost every ligand molecule can be labeled radioactively. However, it requires radiochemical facilities and, in most cases, exposure times of up to several weeks are necessary.
The use of non-radioactive conjugates such as biotin or fluorochromes overcomes these problems. However, for detection of biotin an additional immunohistochemical step is necessary. Fluorochromes can be visualized dnectly. The disadvantages ofthis method are that a fluorescence microscope must be used and that fluorochromes tend to fade very quickly.
The new method that we have developed using Nanogoldlabeled SP combines the advantages of specific receptor-ligand binding with a non-radioactive detection system. The distribution of the gold label can be visualized by a silver enhancement reaction without an additional immunohistochemical incubation. It should be possible to label a great variety of peptides that have an accessible primary amino group. In addition to SP, we have been able to label somatostatin and bradykinin successfully, and they have been used for demonstrating their binding sites in Western blots, histological sections, and cell cultures (data not shown). Other advantages are a short processing time and a high spatial resolution (see darkfield images in Figures 4-7) .
The specificity was clearly shown by the various control experiments. (a) SP predominantly binds at the NK1 receptor. Lcss binding occurs at the NK2 and NK3 receptor (see Mussap et al., 1993) . Therefore, we incubated SF-Nanogold in the presence of an excess of the native SP or a specific NK1 receptor agonist. In both C~SCS, SP-gold binding was almost completely blocked. (b) The addition of neurokinin A, a peptide that predominantly binds at the N K 2 receptor and less at the NK1 receptor (Mussap et al.. 1993) , only slightly reduced the intensity of the SFgold binding in the tissue sections. (c) Incubation with NHS Nanogold showed only a weak and certainly not a specific background staining of the tissue. Because during the labeling process N H S Nanogold has been incubated with an excess of the native peptides, no or only a very small concentration of unbound NHS Nanogold is prexnt in the peptide-gold solution.
In summary, this study shows that SP can be labeled by NHS Nanogold to demonstrate its binding sites in histological sections.
It may be possible that this kind of labeling can be performed on other peptides. The combination of receptor-ligand affinity binding with a non-radioactive detection system shows the following advantages: (a) a very short procedure time, (b) no need for an additional immunohistochemical step, (c) no fading of the signal, and (d) high spatial resolution. Therefore, this new method offers a valuable addition or an alternative to other methods used in the study of the distribution of peptide receptors.
